PDS Biotechnology
PDSB
21 hedge funds and large institutions have $2.76M invested in PDS Biotechnology in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
30% more capital invested
Capital invested by funds: $2.12M → $2.76M (+$638K)
24% more funds holding
Funds holding: 17 → 21 (+4)
3.53% more ownership
Funds ownership: 5.37% → 8.91% (+3.5%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NLVP
New Leaf Venture Partners
New York
|
+$767K |
| 2 |
Renaissance Technologies
New York
|
+$249K |
| 3 |
IWA
Inspirion Wealth Advisors
Libertyville,
Illinois
|
+$140K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$94.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$165K |
| 2 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
-$37K |
| 3 |
BlackRock
New York
|
-$15.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.92K |
PDSB Hedge Fund Activity: Q2 2019 in Review
21 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q2 2019, worth a combined $2.76M — up 30% from $2.12M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PDSB positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was New Leaf Venture Partners, opening a new position worth an estimated $767K. The largest seller was D.E. Shaw & Co, cutting an estimated $165K.
- 21 institutional investors held PDS Biotechnology (PDSB) as of Q2 2019, up from 17 in Q1 2019.
- Funds reported $2.76M of PDS Biotechnology stock for Q2 2019, up 30% quarter-over-quarter.
- 7 funds opened new PDS Biotechnology positions in Q2 2019 and 3 closed out, a net change of +4 holders.
- The largest PDS Biotechnology buyer in Q2 2019 was New Leaf Venture Partners, an estimated $767K added.
- The largest PDS Biotechnology seller in Q2 2019 was D.E. Shaw & Co, an estimated $165K sold.
Based on aggregated 13F filings for Q2 2019.